Avista Public Acquisition Corp. II
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Aug 10, 2021 |
| CEO | David Burgstahler |
| Left Lead | Credit Suisse |
| IPO Cash in Trust | 102.5% |
| SPAC Tenor | 18 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | OmniAb |
| Deal Announced | Mar 23, 2022 |
| Deal Size, $M | $884.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 24, 2022 |
| Amendment Vote | TBD |
| Closing Date | Nov 1, 2022 |
Formerly AHPA
OABI
OABIW
| Price | $1.55 |
|---|---|
| Last closing price | $1.49 |
| H/L, today | $1.48 / $1.56 |
| H/L, 52-week | $1.91 / $5.98 |
| Volume, today | 435,175 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.